Open AccessGlycated Albumin and Risk of Death and Hospitalizations in Diabetic Dialysis Patients
Author(s) -
Barry I. Freedman,
Lilian Andries,
Zak K. Shihabi,
Michael V. Rocco,
Joyce R. Byers,
Cesar Y. Cardona,
Michael A. Pickard,
David L. Henderson,
Margie V. Sadler,
Leah M. Courchene,
Jean R. Jordan,
Somer S. Balderston,
Angie Graham,
Vicki L. Mauck,
Gregory B. Russell,
Anthony J. Bleyer
Publication year - 2011
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.11491210
Subject(s) - medicine , diabetes mellitus , glycemic , glycated hemoglobin , dialysis , hemodialysis , hazard ratio , proportional hazards model , gastroenterology , endocrinology , type 2 diabetes , confidence interval
Relative to hemoglobin (Hb) A(₁c), glycated albumin (GA) more accurately reflects glycemic control in patients with diabetes mellitus and ESRD. We determined the association between GA, HbA(₁c), and glucose levels with survival and hospitalizations in diabetic dialysis patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom